Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $13.46 in the prior trading day, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $13.60, up 1.04%. In other words, the price has increased by $1.04 from its previous closing price. On the day, 9.48 million shares were traded. TEVA stock price reached its highest trading level at $13.83 during the session, while it also had its lowest trading level at $13.27.
Ratios:
Our goal is to gain a better understanding of TEVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.64. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.03.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Daniell Richard sold 70,961 shares for $15.91 per share. The transaction valued at 1,128,642 led to the insider holds 48,384 shares of the business.
Hughes Eric A sold 15,174 shares of TEVA for $238,757 on Mar 04 ’25. The See “Remarks” now owns 8,077 shares after completing the transaction at $15.73 per share. On Mar 05 ’25, another insider, Hughes Eric A, who serves as the See “Remarks” of the company, sold 8,077 shares for $15.91 each. As a result, the insider received 128,531 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 15598656512 and an Enterprise Value of 30651205632. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94 while its Price-to-Book (P/B) ratio in mrq is 2.87. Its current Enterprise Value per Revenue stands at 1.853 whereas that against EBITDA is 6.917.
Stock Price History:
The Beta on a monthly basis for TEVA is 0.67, which has changed by 0.038961053 over the last 52 weeks, in comparison to a change of 0.07019031 over the same period for the S&P500. Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $12.47. The 50-Day Moving Average of the stock is -14.28%, while the 200-Day Moving Average is calculated to be -22.94%.
Shares Statistics:
The stock has traded on average 13.09M shares per day over the past 3-months and 14414600 shares per day over the last 10 days, according to various share statistics. A total of 1.15B shares are outstanding, with a floating share count of 1.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 58.65% stake in the company. Shares short for TEVA as of 1743379200 were 32386482 with a Short Ratio of 2.47, compared to 1740700800 on 27808217. Therefore, it implies a Short% of Shares Outstanding of 32386482 and a Short% of Float of 2.8399997999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.95.
